SCHEMBL12487147

SCHEMBL12487147

Clc1cc(Nc2ccc(Nc3ccccc3)cc2)ncn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.64
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
RAB9A P51151 2/20 0.57
EGFR P00533 3/20 0.53
ERBB3 P21860 2/20 0.53
ALDH1A1 P00352 5/20 0.50
CYP2C19 P33261 3/20 0.50
MAPK1 P28482 3/20 0.50
CYP2D6 P10635 2/20 0.50
TSHR P16473 2/20 0.50
CYP1A2 P05177 2/20 0.50
CLK4 Q9HAZ1 2/20 0.50
CYP3A4 P08684 1/20 0.50
MKNK1 Q9BUB5 1/20 0.49
USP2 O75604 1/20 0.48
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
PTGS1 P23219 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL857502 0.96 NPC1 (0.63) NPC1MEN1KMT2ARAB9AEGFR
Hydrochloric Acid SCHEMBL2176643 0.95 NPC1 (0.61) NPC1MEN1KMT2ARAB9AEGFR
Dioxane SCHEMBL28234086 0.87 NPC1 (0.54) NPC1MEN1KMT2ARAB9AEGFR
SCHEMBL2174012 0.85 SCN9A (0.61) NPC1MEN1KMT2ARAB9AEGFR
SCHEMBL2283204 0.85 NPC1 (0.68) NPC1MEN1KMT2AEGFRERBB3
Hydrochloric Acid SCHEMBL2176150 0.84 NPC1 (0.66) NPC1MEN1KMT2AEGFRERBB3
SCHEMBL414719 0.82 MEN1 (0.70) NPC1MEN1KMT2ARAB9AEGFR
SCHEMBL5025314 0.82 NPC1 (0.64) NPC1MEN1KMT2ARAB9AEGFR
SCHEMBL22328022 0.82 NPC1 (0.64) NPC1MEN1KMT2ARAB9AEGFR
SCHEMBL28805101 0.82 NPC1 (0.69) NPC1MEN1KMT2ARAB9AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519501-B1 SUBSTITUTED PYRIDINES AND PYRIMIDINES FOR THE PRODUCTION OF CARDIOMYOCYTE-LIKE CELLS UNIV WIEN TECH (AT) 2015-04-22 EP disclosed
US-8986994-B2 Substituted pyridines and pyrimidines TECHNISCHE UNIVERSITAET WIEN (AT) 2015-03-24 US disclosed
US-20120294835-A1 SUBSTITUTED PYRIDINES AND PYRIMIDINES MEDIZINISCHE UNIVERSITAET WIEN (AT) 2012-11-22 US disclosed
WO-2011079343-A2 SUBSTITUTED PYRIDINES AND PYRIMIDINES TECHNISCHE UNIVERSITAET WIEN (AT) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120294835-A1 SUBSTITUTED PYRIDINES AND PYRIMIDINES TNNI3, TNNT2, PROX1 NPC1 4262/4885MEN1 4740/4885KMT2A 2502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.